VUSM Logo

The Office of Health Sciences Education, The Office for Continuous Professional Development and
the Academy for Excellence in Education

present

Contact

Mary Ann Nichols 
Vanderbilt University 
maryann.nichols@vanderbilt.edu
615-936-8510 

When

Monday, October 8, 2018 from 12:00 PM to 1:00 PM CDT

Add to Calendar 

Where

202 Light Hall
 

 
 
 

Health Sciences Education Grand Rounds 

Date: Monday, October 8, 2018
Time: 12:00 -1:00 pm
Place: 202 Light Hall
 

"The Future of the Doctorate"

 
Robert Harris, PhD

Professor of Immunotherapy, Department of Clinical Neuroscience
Deputy Vice-President for Doctoral Education, Karolinska Institutet
President ORPHEUS

 

                         A boxed lunch will be provided for all registrants.

Please register below by Friday, October 5, 2018. 

About Professor Harris:

Professor Robert A. Harris (Bob) was born in Harpenden in Southern UK in 1966. He conducted a Bsc.Hons undergraduate degree at Portsmouth Polytechnic, majoring in Parasitology in 1987. PhD studies at University College London studying innate immune agglutinins in Schistosoma host snail species with Terry Preston and Vaughan Southgate as supervisors culminated with a thesis defence in early 1991. A 2.5 year postdoc at the London School of Hygiene & Tropical Medicine in Paul Kaye’s research group ensued, with focus on understanding the intracellular fate of Leishmania spp. protozoans in macrophages. Bob was awarded a Wellcome Trust postdoctoral fellowship that permitted his relocation to the Karolinska Institutet (Stockholm, Sweden) in the spring of 1994. A postdoc period was spent split between the labs of Anders Örn and Tomas Olsson, in which he studied Trypanosoma cruzi and Trypanosoma bruceii protozoan proteins. Bob became an Associate Professor at the Karolinska Institute in 1999, heralding his establishment as a PI. Bob started to work with autoimmune diseases in 1996 and began study of therapy using live parasite infections or parasite molecules. His research group has developed autoantigen-specific vaccines, defined the effects of post-translational biochemical molecules on autoantigenicity and developed a macrophage adoptive transfer therapy that prevents pathogenesis in several experimental disease models. He became Professor of Immunotherapy in Neurological Diseases in 2013.

Professor of Immunotherapy in Neurological Diseases 2013-present
President of ORPHEUS doctoral education organization 2014-present
Central Director of Doctoral studies at Karolinska Institutet 2008-present
Director of Doctoral studies at Department of Clinical Neurosciences, Karolinska Institutet 2005-present
Awarded Karolinska Institutet’s Pedagogy Prize 2014
78 publications and 1 review – Web of Science h index = 21 Google Scholar H index = 29, i index = 60
Currently receives research funding from Swedish Medical research Council, AlzheimerFonden, CancerFonden, BarnCancerFonden and Karolinsk Institutet
Currently supervises 6 PhD students, co-supervises 5 PhD students, 1 Postdoctoral Fellow and one undergraduate student

CME Credit:
Sponsored by Vanderbilt University School of Medicine; Office for Health Sciences Education, Educator Development Core, The Office for Continuous Development and the Academy for Excellence in Education.

Vanderbilt University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Vanderbilt School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity. It is the policy of the ACCME and Vanderbilt University School of Medicine to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity.  Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.